<DOC>
	<DOCNO>NCT02209155</DOCNO>
	<brief_summary>This double-blinded , randomize , parallel , placebo-controlled phase 2 study evaluate safety efficacy R-verapamil prophylaxis episodic cluster headache .</brief_summary>
	<brief_title>R-Verapamil Prophylaxis Episodic Cluster Headache</brief_title>
	<detailed_description>Approximately 30 subject ( 15 per treatment group ) , enrol randomize receive either R-verapamil placebo 2 week . The study consist 1-week run-in period 2-week treatment period ( R-verapamil placebo ) . The total duration study treatment group 3 week .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Healthy man woman age 18 65 In good health determine medical history medical examination Has diagnosis episodic cluster headache define International Classification Headache Disorders ( 2nd edition ) Has lifetime prevalence least 2 prior cluster bout Subjects must experience least 7 attacks/week runin baseline period Subjects must typical cluster period last least 1 month . Subjects must present active cluster period expect remain duration cluster cycle must least 3 week Baseline Day 1 visit Able differentiate headache type cluster headache Is use agrees use medically acceptable form contraception ( female childbearing potential ) Negative urine pregnancy test prior study entry ( female childbearing potential ) Concomitant medication , opinion investigator patient 's general practitioner ( GP ) , pose unacceptable risk base upon prescribe information verapamil Able understand comply study requirement Written inform consent Women pregnant lactating Subjects , investigator opinion , history evidence medical psychiatric condition would expose increase risk significant adverse event would interfere assessment efficacy tolerability Use drug medical condition might interact adversely , interfere action , study medication The concomitant use beta blocker The consumption grapefruit juice Allergic show hypersensitivity verapamil agent similar verapamil Abuses opioids history significant drug alcohol abuse within past year determine investigator Has participate investigational drug trial 30 day prior screen visit Has liver kidney disease Has cardiopathology contraindicate verapamil administration Subjects previous adynamic ileus . Subjects chronic cluster headache Use antipsychotic , antidepressant , lithium prophylactic treatment le one month prior inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>